The history of the HIV and AIDS epidemic began in illness, fear and death as the world faced a new and unknown virus. However, scientific advances, such as the development of antiretroviral drugs, have enabled people with access to treatment to live long and healthy lives with HIV.
Three recent exhibitions show that though HIV is no longer a death sentence, the art world is still grappling with its psychological toll.
Many outlets are reporting that scientists have spotted a new strain of HIV for the first time in almost two decades. It would be reasonable to assume this was bad news. It certainly sounds as if the virus, which can lead to AIDS if it’s not treated, is suddenly mutating and on the move. But this is far from the truth. In fact, this new strain of HIV is actually *good* news.
For starters, the “new” strain is… not new.
Every time I tell someone I’m positive, I think of you. Not in anger, or resentment, but of the things about you that make me smile.
Communities have a critical role to play in ensuring that prevention interventions move from the realm of proven efficacy to real-world effectiveness.
A range of new HIV prevention technologies, such as treatment and prevention, including the oral Pre-exposure Prophylaxis (PrEP) and voluntary medical male circumcision, are now available. Yet global HIV incidence has declined by less than 2% per year since 2010.
Research shows that these new HIV prevention modalities – such as PrEP – are underutilised. In addition, 38.5% of those infected are not receiving treatment. Retention in care remains suboptimal.
For 35 years, researchers have been trying to beat the virus that causes AIDS. For just as long, Burt Dorman has been advocating another way.
HIV is the most feared STD out there—but should it be?
What does all of this mean for the ongoing battle against HIV? When either making scrambled eggs or battling an infectious disease, you can't beat what you can't find.
Luckily, HIV is not the death sentence it was just 40-years ago and stigma around the disease has waned. With research teams staying vigilant and interconnected there is hope that HIV will never again ravage families as communities, and indeed, that a cure may be in sight.
The drug Truvada, or PrEP, has helped drastically reduce new HIV infections, but taking a daily pill can be onerous. Now there might be other options.
Experts say the booming population of young women in sub-Saharan Africa means global infections could start rising.
The president said he wants to eradicate the virus. That would mean a radical reversal of his policy and rhetoric.
There are an estimated 5000 new HIV transmissions every day. Around 70% of the 37 million people living with HIV globally are in sub-Saharan Africa. Of the 1.8 million new HIV transmissions worldwide in 2017, 800 000 occurred in eastern and southern Africa. New, effective prevention strategies are essential to reducing HIV transmission.
So what will it take to reduce HIV transmission? Prevention.
Only a handful of exposed children are currently tested for HIV and started on treatment in the first week of life. South Africa has recently changed its policy to test children at birth and 10 weeks, but it is the only country in Africa to do so. All others have policies to test babies for HIV when they reach between four and six weeks old, by which time the viral burden in the body is high and signs of a weakened immune system may be apparent.
Don’t look to Canada, France, or Singapore for a world-class health care system. You can get the best health care in the world right here in the United States, for free. But there’s a catch: You have to be HIV-positive.
Through a combination of federal and state funding, plus some very clever implementation strategies, Americans infected with HIV are eligible for incredibly comprehensive care, even if they are uninsured or underinsured. It’s amazing the program doesn’t get the attention it deserves. In fact, it should be a model for how we treat all patients.
The blockbuster news that a second HIV patient is in full remission shows us the limitations of our language.
A panoply of drugs in recent years has allowed some people with H.I.V. to have almost the same life expectancy as the general population.
But perhaps even more striking has been the development of a drug known as PrEP, for pre-exposure prophylaxis. It enables anyone at risk of contracting H.I.V. — through unprotected sex, for example — to ward off the virus by taking a daily pill.
A veteran medical journalist for The New York Times remembers covering the indifference, confusion, and fear of the epidemic's early years.
1988 was a weird time to be a 14-year-old gay kid in America. One could find representations of gay men all over the place. They were profiled in People magazine, discussed in segments on the national news, and interviewed by a doggedly sympathetic Phil Donahue before a live studio audience.
But they were also dying.
Africa is more heavily affected by HIV and AIDS than any other region of the world. The social impact is most evident in Africa’s growing orphan population. Alicia Keys co-founded “Keep a Child Alive” and has become one of the most powerful women in the fight against HIV/AIDS.
Why do America’s black gay and bisexual men have a higher H.I.V. rate than any country in the world?
More than 90 percent of new HIV infections come from people not receiving medical care for the disease. And 30 percent of new infections were transmitted from people who don't know they have HIV.
The question of whether or not there are promising treatments in development for HIV is complicated. Scientists do have potential paths forward to cure HIV infections but they don’t make any practical sense since physicians shouldn’t resort to aggressive cures for HIV when the current anti-retroviral therapies (ART) for HIV are far less risky.
Around 80 percent of those were in eastern Europe, the report found.
Attempts to cure HIV have been thwarted by a particular type of immune-system cell that can hide the virus. These long-lived infected T cells can evade detection by the body for years, and are hard to find, study and kill. Reliably identifying these covert reservoirs is top of the wish-list for HIV researchers, but they've had limited success.
PrEP drugs like Truvada can drastically lower the risk of HIV transmission. But young women in South Africa are pushing for a different kind of change.
HIV/AIDS has always been one of the most thoroughly global of diseases. In the era of widely available anti-retroviral therapy (ART), it is also commonly recognised as a chronic disease that can be successfully managed on a long-term basis.
About 15 years ago he first considered using HIV to kill cancer cells. At the time, he says, “the rest of the community that did cancer immunotherapy had all been using viruses out of mice, called gammaretroviruses. And it turns out the HIV works better with human T-cells than the mouse virus does.”
In 2002, when I first started working on HIV/AIDS in southern Africa, my friends and colleagues devoted every weekend to attending funerals. At that time, the antiretroviral drugs that were keeping people alive in New York and San Francisco were almost nowhere to be found in Africa, and the disease swiftly ravaged its victims.
Fifteen years later, the epidemic has turned a corner in three African countries that are at the epicenter of the crisis. In Zimbabwe, Malawi, and Zambia...
Three decades after the rise of HIV terrorized the world, many misunderstandings attached to the disease remain — from misconceptions about whom it affects to confusion about how it’s actually transmitted.
More than one in three Americans, a Kaiser Family Foundation survey found, hold at least one wrong belief about HIV transmissions.
The government refuses to acknowledge that it isn't supporting more than a million people infected by HIV/AIDS.
Reservoirs of HIV hide deep within the body. Scientists are now closing in on methods to wipe them out.
Michael Weinstein’s AIDS Healthcare Foundation treats an enormous number of patients — and makes an enormous amount of money. Is that why so many activists distrust him?
The “mosaic vaccine” tackles the virus’s incredible genetic diversity.
If you've ever asked who brought AIDS to the United States, you've likely been told that "Patient Zero" was a man called Gaëtan Dugas.
The Canadian flight attendant was blamed for carrying the virus from Africa and spreading it around the gay community in North America.
Yet antiretroviral therapy can turn the deadly disease into a manageable chronic condition.
orld AIDS Day is, like other world disease days, a publicity gambit that has a distinctly absurd pageantry. But there is substance beyond candlelight vigils, a red ribbon hung from the White House portico, and proclamations from politicians and public health officials. Most tangibly, each World AIDS Day, held annually on Dec. 1, broadcasts official updates about the damage caused by HIV, which at last count had infected 78 million people since the epidemic surfaced in 1981 and had killed half of them. And beginning in 2012, World AIDS Day began to trumpet a new possibility that a few years earlier would have seemed preposterous, even delusional: ending the epidemic.
The United Nations announced today that the global HIV/AIDS epidemic could be slowed to a trickle within the next two decades. Can it be done?
AIDS first emerged in the early 1980s, claiming thousands of lives each year as it spread. But it wasn't until the disease reached pandemic status more than a decade later that the global community really galvanized in an effort to stop it.
We are closer to eliminating HIV than ever before – binding communities, scientists, and political leaders together to envision a different future.
Welcome to the AIDSPortal website - the online resource supporting the community response to HIV. Search for HIV & AIDS and health related information, contribute your experiences and connect to people, groups and organisations from around the world. Content can be viewed in more than 50 languages.
HIV/AIDS treatment, prevention, research & clinical trials
The world is talking about ending AIDS. AVAC’s advocacy is dedicated to realizing that vision. Founded in 1995, AVAC is an international non-profit organization that uses education, policy analysis, advocacy and community mobilization to accelerate the ethical development and eventual global delivery of AIDS vaccines and other new HIV prevention options as part of a comprehensive response to the pandemic.
AVERT’s Community Programme supports and builds partnerships with local organisations who are working to directly avert the spread of HIV and AIDS, and to improve the treatment, care and support of people infected with, or affected by HIV and AIDS. AVERT’s current HIV and AIDS projects, and partnerships are taking place in southern Africa, particularly in areas where there are extremely high rates of HIV infection.
GREATER THAN AIDS is a leading public information response to the U.S. domestic HIV/AIDS epidemic with a focus on areas and people most affected.
Launched in March 1997, HIV InSite's mission is to be a source for comprehensive, in-depth HIV/AIDS information and knowledge. The site has an extensive collection of original material, including the HIV InSite Knowledge Base, a complete textbook with extensive references and related links organized by topic.
The HIV Vaccine Trials Network is an international collaboration of scientists and educators searching for an effective and safe HIV vaccine.
HIV.gov models the effective use of digital media to strengthen our public health work and empower partners to more effectively achieve their missions.
To realize the end of AIDS for children and their families, by
combating the physical, social and economic impacts of HIV.
The mission of the National AIDS Memorial is to provide, in perpetuity, a place of remembrance so that the lives of people who died from AIDS are not forgotten and the story is known by future generations.
Our mission is to educate individuals about HIV and Hepatitis treatments and to advocate on the behalf of all people living with HIV/AIDS and HCV.
Welcome! Looking for the latest news? Campaign ideas? Prevalence data for your area? NPIN is here to provide you with the most current HIV/AIDS resources, tools, and ideas to support your organization’s efforts to prevent HIV/AIDS.
POZ is America’s premier lifestyle, treatment and advocacy magazine and website for people living with—and those affected by or looking for more information about—HIV and AIDS. It informs, inspires and empowers its readership.
TheBody.com's mission is to:
Use the Web to lower barriers between patients and clinicians.
Demystify HIV/AIDS and its treatment.
Improve the quality of life for all people living with HIV/AIDS.
Foster community through human connection.
Founded in 2002, TheBodyPro exists to inform and support the HIV workforce -- the vast constellation of people working on the front lines of HIV education, prevention, care, and services. Whether you're a physician or a case manager; a registered nurse or a licensed social worker; a medical technician or a therapist; we're here to provide you with up-to-date information, valuable perspectives, and authentic professional voices.
UNAIDS is leading the global effort to end AIDS as a public health threat by 2030 as part of the Sustainable Development Goals.
With no cure and no vaccine for AIDS currently available, the only way we can stop HIV is to prevent its spread.
We provide free, confidential, accurate, non-judgmental information about sex and reproductive health. If you have a question about sex, we'll either answer it or refer you to someone who can.
While there have been great strides in the prevention of HIV transmission and care of HIV infection and AIDS since AIDS was first recognized in 1981, many people still have questions about HIV and AIDS. The information below is designed to answer some of these questions based on the best available science.
Since the first cases of AIDS were identified in 1981, tens of millions of people around the world have become infected with HIV, and the epidemic has claimed millions of lives.
HIV infections: sites, fact sheets, links, features